Article
Cover
RJDS Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol No: 16 Issue No: 3   pISSN: 

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Review Article
Sachin S Shivanaikar*,1,

1Reader, Maratha Mandal’s NGH Institute of Dental Sciences, Near KSRP ground RS no 47A/2 Bauxite Road. Belagavi, Karnataka.590 010.

*Corresponding Author:

Reader, Maratha Mandal’s NGH Institute of Dental Sciences, Near KSRP ground RS no 47A/2 Bauxite Road. Belagavi, Karnataka.590 010., Email: drsachinshivanaikar@yahoo.co.in
Received Date: 2014-12-20,
Accepted Date: 2015-01-20,
Published Date: 2015-01-31
Year: 2015, Volume: 7, Issue: 1, Page no. 33-42,
Views: 715, Downloads: 17
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Sex hormones have long been considered to play an influential role on periodontal tissues, bone turnover rate, wound healing and periodontal disease progression. This review focuses on the effects of sex hormones on the periodontium. This review article will analyse how these hormones influence the periodontium at different life stages such as puberty, menstruation, pregnancy, menopause and post-menopause. Moreover, the effects of contraceptives and hormone replacement therapies on the periodontium will be discussed. It is clear that endogenous sex steroid hormones play significant roles in modulating the periodontal tissue responses. A better understanding of the periodontal changes to varying hormonal levels throughout life can help the dental practitioner in diagnosis and treatment. 

<p>Sex hormones have long been considered to play an influential role on periodontal tissues, bone turnover rate, wound healing and periodontal disease progression. This review focuses on the effects of sex hormones on the periodontium. This review article will analyse how these hormones influence the periodontium at different life stages such as puberty, menstruation, pregnancy, menopause and post-menopause. Moreover, the effects of contraceptives and hormone replacement therapies on the periodontium will be discussed. It is clear that endogenous sex steroid hormones play significant roles in modulating the periodontal tissue responses. A better understanding of the periodontal changes to varying hormonal levels throughout life can help the dental practitioner in diagnosis and treatment.&nbsp;</p>
Keywords
Periodontitis Periodontium, Sex Hormones
Downloads
  • 1
    FullTextPDF
Article

INTRODUCTION

Periodontitis is a complex disease in which disease expression involves intricate interactions of the Biofilm with the host immune-inflammatory response and subsequent alterations in bone and connective tissue homeostasis.1,2 However, it has also been shown that without a susceptible host the periodontal pathogens are necessary but not sufficient for disease to occur. Hence, the systemic factors/conditions of the host must be understood since they may affect disease prevalence, progression, and severity.3 Among these, sexual hormones have been suggested as important modifying factors that may influence the pathogenesis of periodontal diseases.4 Hormones are specific regulatory molecules that modulate reproduction, growth and development and the maintenance of internal environments as well as energy production, utilization and storage.5 Reports of the effects of sex steroid hormones in the Periodontium have been noted for over a century. Currently accepted periodontal disease classification recognizes the influence of endogenously produced sex hormones on the periodontium. Under the broad category of dental plaque induced gingival diseases that are modified by systemic factors, those associated with the endocrine system are classified as puberty, menstrual cycle and pregnancy associated gingivitis.6 The goal of this review article is to provide the reader with current information about the relationship between sex steroid hormones and cells of the periodontium.

Because of their complexity and diversity, hormones are difficult to arrange into discrete groups, although they can be divided into four subgroups based upon their chemical structure – steroids, glycoproteins, polypeptides, and amines. Steroid sex hormones are derived from cholesterol and as a common structure they have three rings of six carbon atoms. They are believed to play an important role in the maintenance of the skeletal integrity, including the alveolar bone. The steroid sex hormones such as estrogen and estradiol have been known for their effect on bone mineral metabolism. Other bone turnover-related hormones include progesterone, testosterone and dihydrotestosterone, and rostenedione, dihydroepiandrostenedione, and sex hormone-binding globulin. Among these, estrogens, progesterone, and testosterone have been most linked with periodontal pathogenesis.7

Androgens (Testosterone)

All natural androgens are derived from a 19-carbon tetracyclic hydrocarbon nucleus known as androstane. One of the most potent androgenic hormones, testosterone is synthesized by the Leydig's cells of the testes, the thecal cells of the ovary and the adrenal cortex. In men, testosterone is the principal plasma androgen and is reduced to dihydrotestosterone the mediator of most actions of the hormone. There are two types of androgens: gonadal androgen, dihydrotesterone (DHT), and adrenal androgen, dehydroepiandrosterone.

Androgens may play a significant role in the maintenance of bone mass and inhibit osteoclastic function, inhibit prostaglandin synthesis and reduce interleukin-6 (IL-6) production during inflammation8, testosterone stimulates bone cell proliferation and differentiation and therefore has a positive effect on bone metabolism.9 Specific receptors for these hormones have been isolated in the periodontal tissues.10 Testosterone has also been associated with bone metabolism, playing a role in the maintenance of bone mass.11 A very effective way to analyze the effect of androgens on bone metabolism is the evaluation of the presence of biochemical markers of bone remodeling on bone tissue under the influence of those hormones. One of the bone remodeling markers that has been used for this objective is osteoprotegerin (OPG), which is a secreted decoy receptor that inhibits osteoclast formation and activation by neutralizing its cognate ligand12 During periodontal disease progression, OPG action is associated with a reduction in the loss of bone mineral density13 and serum concentrations of OPG increase significantly with age, and are positively correlated with free testosterone index and free estradiol index14. Effects of Androgens on periodontium are given in Table 1.9,14-17

Estrogen and Progesterone

Estrogen and progesterone are responsible for physiological changes in women at specific phases of their life, starting in puberty. Estrogen induces several of the pubertal developmental changes in females, and progesterone acts synergistically with estrogen to control the menstrual cycle and to inhibit follitroppin secretion by the anterior pituitary gland18 Estrogen and progesterone have significant biological actions that can effect other organ systems including the oral cavity19 Estrogen receptors found in osteoblast-like cells provide a mechanism for the direct action on bone, These receptors were also located in periosteal fibroblasts, scattered fibroblasts of the lamina propria20 and periodontal ligament (PDL) fibroblasts. Progesterone is another sex hormone that has also been demonstrated to have direct effects on the Periodontium. It is active in bone metabolism and may play an important role in the coupling of bone resorption and bone formation21. It may exert its action directly on bone by engaging osteoblast receptors or indirectly by competing for a glucocorticoid receptor22. Effects of Estrogen and Progesterone on periodontium is given in Table 223-28 & Table 37&29-34.

Factors influencing the effect of sex hormones on periodontium

Gender

Studies have reported that 80% of the osteoporotic patients are female, correlating with the higher frequency of hip fractures in females, who are also more likely to experience hormonal imbalance throughout their lives than males35. it was found that the residual ridge in women is lower than that in men36 this might be associated with the decreased amount of circulating estrogen found in women during menopause, since this condition is associated with a higher frequency of alveolar bone height loss, as well as decreased crestal and subcrestal bone density.37

Age

The biological changes on the periodontal tissues during different time points such as puberty, the menstrual cycle, pregnancy, menopause, and oral contraceptive use have heightened interest in the relationship between steroid sex hormones and the health of the periodontium.

Puberty

Along with the dramatic rise in female sex steroid levels during the circumpubertal period, several cross-sectional and longitudinal studies have demonstrated an increase in gingival inflammation without an accompanying increase in plaque levels38 Several studies have noted a concomitant increase in subgingival black-pigmented anaerobic bacteria that parallels the onset of puberty and the increase in gingival inflammation observed during this time39 It has been suggested that these gram-negative bacteria are able to substitute estradiol and progesterone for menadione, an essential vitamin K growth factor for this bacterium40 A study evaluating increased serum estradiol and progesterone levels during puberty noted a positive correlation with significant increases in proportion, number, and serum IgG antibody levels to Prevotella intermedia41 Changes in Periodontium in puberty is summarised in Table 4.5,41

Menstrual Cycle

The onset of increased production, and secretion of estrogen and progesterone in a cyclic pattern accompanies the onset of puberty and is referred to as the reproductive or menstrual cycle. Significant and observable gingival inflammatory changes have been documented in association with the menstrual cycle42 Progesterone has been associated with increased permeability of the microvasculature, altering the rate and the pattern of collagen production in the gingiva43 increases folate metabolism 34 stimulates the production of prostaglandins and enhances the chemotaxis of polymorphonuclear leukocytes (PMNL)44 during the menstrual cycles, women without clinical gingivitis showed no increase in gingival fluid, whereas those with gingivitis showed increases in gingival fluid. In addition to gingival inflammation, intraoral recurrent aphthous lesions45 Changes in Periodontium during menstrual cycle is summarised in Table 5.33,42

Pregnancy

The hormonal changes that occur during pregnancy include an elevation of both progesterone and estrogen. By the end of the third trimester, progesterone and estrogen reach peak plasma levels of 100 ng/ml and 6 ng/ml respectively, which represents 10 and 30 times the levels observed during the menstrual cycle46 Susceptibility to infections increases during early gestation due to alterations in the immune system and can be explained by the hormonal changes observed during pregnancy, suppression on T-cell activity47 decreased neurophil chemotaxis and phagocytosis, altered lymphocyte response and depressed antibody production48 chronic maternal stress, and even nutritional deficiency associated with increased nutritional demand by both the mother and the fetus. These immunologic changes might also be responsible for periodontal pathologic conditions observed during pregnancy such as pregnancy gingivitis49, pregnancy granuloma, periodontitis, and dental caries. The increased synthesis of PGE2 observed when estradiol and progesterone are present in higher concentrations, such as occurs during pregnancy, may also contribute to these pathologic changes. periodontal pathogens such as Prevotella Intermedia (Pi) and Porphyromonas gingivalis (Pg) can also use female sex hormones such as progesterone or estradiol as a source of nutrients. These bacteria are generally increased in the gingival crevicular fluid of pregnant women, a situation that is positively correlated with the severity of pregnancy gingivitis.7

Apart from a transient increase in bleeding, gingivitis and a subgingival microbial shift, pregnant women in good health are unlikely to experience any significant gingival response that would have serious clinical implications. Although pregnant women with Periodontitis may not experience exacerbation of their periodontal condition, it would be prudent to seek treatment to avoid periodontal abscess formation that may cause bacteremia. In general, pregnant women should note that preventive measures consisting of dental prophylaxis and meticulous plaque control help to prevent development of any periodontal condition. Clinical and microbial changes is summarised in Table 6.50-55

Contraceptives

Hormonal contraceptives are based on the use of gestational hormones inducing a hormonal condition that simulates a state of pregnancy to prevent ovulation. However, the use of oral contraceptives carries a number of significant implications for the health of women. A number of studies have shown various effects of contraceptive influence on gingival tissue. It was found that there was an increase in clinically assessed inflammation for women using oral contraceptives56, and an increased amount of gingival exudate following 12 months of regular use of oral contraceptives57. As well as these signs, there are no significant differences in plaque index and gingival index scores and attachment level between the oral contraceptive group and the controls58. However, a 16-fold-increase in Bacteroides species has been noted in the oral contraceptive user group versus a non-pregnant group despite the lack of statistically significant clinical differences in gingival index or crevicular fluid59 Effect on peridontium by the use of contraceptives is summarised in Table 7.43,60,61

Menopause and Post menopause

Menopause usually begins between 45 and 55 years of age unless accelerated by hysterectomy and/or ovariectomyIn the premenopausal women, the principal circulating estrogen is 17b-estradiol. As women approach menopause, the levels of estrogen begin to drop mainly during the late follicular and luteal phase of the menstrual cycle62. Progesterone is another sex hormone that may play an important role in bone metabolism during pre- and post menopause. It is believed that ovarian deficiency and associated alterations, but not aging, are the predominant causes of bone loss during the first two decades after menopause63. Researches have shown that progesterone may compete with glucocorticoids for an osteoblast receptor and inhibit the glucocorticoid-induced osteoporosis. Therefore, postmenopausal bone density reduction may be the result of a combination of the inhibition of osteoclast downregulation by reduced estrogen and the increased cortisol inhibition of osteoblasts via the reduction of competition with progesterone7. Osteoporosis is also responsible for less crestal alveolar bone per unit volume, a condition that may promote quicker bone loss when encountered with infections such as periodontal infections64. Eighty-five osteoporotic women demonstrated a significant correlation between skeletal bone mass and the number of teeth remaining in the Mandible. The results demonstrated that the height of the edentulous ridge correlated with total body calcium and mandibular mass65 All of these studies speculated osteopenia is a risk factor for periodontal disease in postmenopausal women. Changes in periodontium during menopause and post menopause is summarised in Table 8.66-68

Hormone replacement Therapy

Peri or postmenopausal women take hormone replacement therapy (HRT) for relieving climacteric symptoms and increasing the quality of lif e . Symptoms of the c lima c t e ri c and postmenopausal period have been shown to disappear with administration of exogenous estrogens, either alone or in combination with progestogens,although hormonal replacement in an adequate dosage can slow or prevent bone loss. Only a small percentage of postmenopausal women receive such therapy, and many who do fail to comply with the prescribed regimen because of the fear of cancer, irregular bleeding, and other minor side effects69. Progesterone alone is not effective in preventing postmenopausal bone and tooth loss, but when combined with estrogen it is believed to uncouple formation and resorption to diminish bone resorption induced by estrogen7. The available data indicate that hormone replacement therapy should be suggested for women during menopause since several pathologic conditions common during this period of time can be avoided or at least reduced in severity.Effect of HRTon peridontium is summarised in Table 9.70-72

Influence of Sex Hormones on Periodontal /Implant Wound Healing

At a molecular level, research has also shown that sex hormones have a regulatory effect on growth factors involved in the wound healing such as the keratinocyte growth factor73 which has been known to have wound healing regulatory effect including stimulation of proliferation, migration, and morphogenesis of pluripotential cells. However, the influence of sex hormones on periodontal wound healing is still largely unknown.

CONCLUSION

It is evident from this review that multifactorial mechanisms involving the endocrine system are involved to a significant degree in the homeostasis of the periodontium during each of the life stages of the human female. The notable periodontal changes related specifically to female sex steroid levels, primarily those manifested as pathologic alterations in the gingiva, attest to the dramatic potential these hormones possess to impact the oral tissues beyond normal homeostatic functions. Nevertheless, it is also apparent that female sex steroid hormones are neither necessary, nor sufficient to produce pathologic gingival alterations by themselves, and attests to the need for further elucidation of the biomolecular mechanisms at work to fully understand how these hormones may exert their significant effects.

Supporting File
No Pictures
References
  1. Offenbacher S, Barros SP, Singer RE, Moss K, Williams RC, Beck JD. Periodontal disease at the biofilm-gingival interface. J Periodontol 2007;78:1911-25. 
  2. Taubman MA, Kawai T, Han X. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J Clin Periodontol 2007;34:367-9. 
  3. Lang, N. P., Kiel, R. A. & Anderhalden, K. Clinical and microbiological effects of subgingival restorations with overhanging or clinically perfect margins. J Clin Periodontol 1983;10:563–578. 
  4. Hofbauer, L. C. & Heufelder, A. E. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. Journal of Molecular Medicine 2001;79:243–53.
  5. Mariotti A. Sex steroid hormones and cell dynamics in the periodontium. Crit Rev Oral Biol Med 1994;5:27-53. 
  6. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6. 
  7. Mascarenhas P, Gapski R, Al-Shammari K, Wang H-L: Influence of s ex hormones on the periodontium. J Clin Periodontol 2003; 30: 671-81.
  8. Morley JE. Testosterone in contemporary endocrinology. In: Morley JE, Lucretia B, eds. Endocrinology of aging. New Jersey:Humana Press Inc, 1999;127-149. 
  9. Kasperk CH, Wakley G, Hierl T, Ziegler R. Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res 1997;12:464-71. 
  10. Wilson, J. D. & Gloyna, R. E. The intranuclear metabolism of testosterone in the accessory organs of reproduction. Recent Progress in Hormone Research 1970;26, 309–36. 
  11. Morley J. E. Testosterone in Contemporary endocrinology: 2000. endocrinology of aging. Morley J. E. & Van der Berg, L., p. 127149. Totowa, NJ: Humana Press Inc. 
  12. Teitelbaum S. L. Bone resorption by osteoclasts. Science 2000;289: 1504–08. 
  13. Kong YY, Yoshida H, Sarosi I,. OPGL is a key regulator of osteoclastogenesis , lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-23. 
  14. Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab2001; 86:3162-65. 
  15. Parkar M., Tabona, P., Newman, H. & Olsen, I. IL-6 expression by oral fibroblasts is regulated by androgen. Cytokine 1998b;10: 613– 19. 
  16. Ojanotko A., Nienstedt, W. & Harri, M. P. Metabolism of testosterone by human healthy and inflamed gingiva in vitro. Archives of Oral Biology 1980; 25: 481–4. 
  17. ElAttar T. M., Lin, H. S. & Tira, D. E. Testosterone inhibits prostaglandin formation by human gingival connective tissue: relationship to 14C-arachidonic acid metabolism. Prostaglandins and Leukotrienes in Medicine 1982; 9, 25–34.
  18. Amar, S. & Chung, K. M. Influence of hormonal variation on the periodontium in women. Periodontology 2000 1994;6: 79–87. 
  19. Sooriyamoorthy M, Gower DB. Hormonal influences on gingival tissue: relationship to periodontal disease. J Clin Periodontol 1989;16:201-8. 
  20. Aufdemorte, T. B. & Sheridan, P. J. Nuclear uptake of sex steroids in gingiva of the baboon. J Periodontol 1981;52: 430–4. 
  21. Lobo, R. A., McCormick, W., Singer, F. & Roy, S. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopaus a l women. Obst e tri c s and Gynecology 1984;63: 1–5. 
  22. Feldman, D., Dziak, R., Koehler, R. & Stern, P. Cytoplasmic glucocorticoid binding proteins in bone cells. Endocrinology 1975; 96: 29–36. 
  23. Lindhe J, Branemark P. Changes in microcirculation after local application of sex hormones. J Periodontal Res 1967;2:185- 93. 
  24. Ito I, Hayashi T, Yamada K, Kuzuya M, Naito M, Iguchi A. Physiological concentration of estradiol inhibits polymorphonuclear leukocyte chemotaxis via a receptor mediated system. Life Sci 1995;56:2247-53. 
  25. Hofmann R, Lehmer A, Braun J, Bauer S. Activity of phagocytic granulocytes in patients with prostatic cancer. UrolRes 1986;14:327-30.
  26. Josefsson E, Tarkowski A, Carlsten H. Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992;142:67-78.
  27. Gordon CM, LeBoff MS, Glowacki J. Adrenal and gonadal steroids inhibit IL-6 secretion by human marrowcells. Cytokine 2001;16:178-86. 
  28. Beagrie GS. Observation on cell biology of gingival tissue of mice. Br Dent J 1966;121:417-20. 
  29. Abraham-Inpijn, L., Polsacheva, O. V. & Raber-Durlacher, J. E. The significance of endocrine factors and microorganisms in the development of gingivitis in pregnant women. Stomatologiia (Mosk)(1996); 75:15–18. 
  30. Smith, M. A., Lucie, N. P., Ferguson, M. M., Mairs, R. J. & Smith, J. G. Progesterone inhibits proliferation of human marrowcolony forming cells (CFU-GM) through increased prostaglandin p r o d u c t i o n b y m a rr o w m a c r o p h a g e s. BritishJournal of Haematology 1986;63: 649–58. 
  31. Chen TL, Aronow L, Feldman D. Glucocorticoid receptors and inhibition of bone cell growth in primary culture. Endocrinology 1977;100:619-28. 
  32. Genco RJ. Risk factors for periodontal disease. In: Cohen DW, Rose LF, Genco RJ, Mealey BL, eds. Periodontal Medicine. Hamilton, Ontario, BC: Decker Inc, 2000;11-34. 
  33. ElAttar TM. Prostaglandin E2 in human gingiva in health and disease and its stimulation by female sex steroids. Prostaglandins 1976;11:331-41. 
  34. Pack ARC, Thomson ME. Effects of topical and systemic folic acid supplementation on gingivitis in pregnancy. J Clin Periodontol 1980;7:402-14. 
  35. Lau, E. M., Suriwongpaisal, P., Lee, J. K., Das De,S., Festin, M. R., Saw, S. P.et al . Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study. Journal of Bone and Mineral Research 2001;16, 572–80. 
  36. Hirai, T., Ishijima, T., Hashikawa, Y. & Yajima, T. Osteoporosis and reduction of residual ridge in e d e n t u l o u s p a t i e n ts. J P ro st h e t D e n t 1993;69:49–56. 
  37. Payne, J. B., Reinhardt, R. A., Nummikoski, P. V. & Patil, K. D. Longitudinal alveolar bone loss in postmenopausal osteoporotic/ osteopenic women. Osteoporosis international 1999;10:34–40. 
  38. Hefti A, Engelberger T, Buttner M. Gingivitis in Basel school children. Helv Odontol Acta 1981; 25: 25–42. 
  39. Delaney J, Ratzan S, Kornman K. Subgingival microbiota associated with puberty: studies of pre-, circum, and postpubertal human females. Pediatr Dent 1986; 8: 268–75.
  40. Kornman KS, Loesche WJ. Effects of estradiol and progesterone on Bacteroides melaninogenicus. J Dent Res 1979;58A: 107. 
  41. Nakagawa S, Fujii H, Machida Y, Okuda K. A longitudinal study from prepuberty to puberty of gingivitis. Correlation between the occurrence of Prevotella intermedia and sex hormones. J Clin Periodontol 1994; 21: 658–65. 
  42. Holm-Pedersen P, Loe H. Flow of gingival exudate as related to menstruation and pregnancy. J Periodontal Res 1967; 2: 13–20.
  43. Ottomo-Corgel J, Steinberg BJ. Periodontal medicine and the female patient. In: Rose LF, Genco RJ, Mealey BL, Cohen DW, eds. Periodontal Medicine. Hamilton, Ontario, BC: Decker Inc, 2000:151-67. 
  44. Miyagi M, Aoyama H, Morishita M, Iwamoto Y. Effects of sex hormones on chemotaxis of human peripheral polymorphonuclear leukocytes and monocytes. J Periodontol 1992;63:28-32. 
  45. Ferguson J, Carter J, Boyle P. An epidemiological study of factors associated with recurrent aphthae in women. J Oral Med 1984; 39: 212. 
  46. Zachariasen R. Ovarian hormones and oral health: pregnancy gingivitis. Compend Contin Educ Dent 1989; 10: 352-356. 
  47. Priddy, K. D. Immunologic adaptations during pregnancy. Journal of Obstetrics, Gynecology and Neonatal Nursing 1997;26: 388– 94. 
  48. Zachariasen, R. D. The effect of elevated ovarian hormones on periodontal health: oral contraceptives and pregnancy.Women Health 1993; 20: 21-30. 
  49. Silness, J. & Loe, H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandanavia 1964; 22: 121-35. 
  50. Miyazaki H, Yamashita Y, Shirahama R, et al. Periodontal condition of pregnant women assessed by CPITN. J Clin Periodontol 1991;18:751-4. 
  51. Tilakaratne A, Soory M, Ranasinghe AW, et al. Periodontal disease status during pregnancy and 3 months post-partum in a rural population of Sri-Lankan women. J Clin Periodontol 2000;27:787- 792. 
  52. Löe H, Silness J. Periodontal disease in pregnancy (I). Prevalence and severity. Acta Odontol Scand 1963;21:533-551. 
  53. Hugoson A. Gingivitis in pregnant women. Odontol Revy 1971;22:65-84. 
  54. ElAttar TM. Prostaglandin E2 in human gingiva in health and disease and its stimulation by female sex steroids. Prostaglandins 1976;11:331-341. 
  55. Kornman KS, Loesche WJ. The subgingival microflora during pregnancy. J Periodontal Res 1980;15:111-122. 
  56. el-Ashiry GM, El-Kafrawy AH, Nasr ME Younis N.Effects of oral contraceptives on the gingiva. J Periodontol 1971; 42: 273-75. 
  57. Lindhe J, Bjorn AL. Influence of hormonal contraception on the gingiva of women. J Periodont Res 1967;2: 1-6. 
  58. Knight GM, Wade AB. The effects of hormonal contraception on the human periodontium. J Periodontal Res 1974;9:18-22.
  59. Jensen J, Liljemark W, Bloomquist C. The effect of female sex hormones on subgingival plaque. J Periodontol 1981;52:599- 602. 
  60. Lindhe J, Influence of hormonal contraceptives on the gingivitis of women. J Periodontal Res 1967;2:1-6. 
  61. Laufer N, Navot D, Schenker JG. The pattern of luteal phase plasma progesterone and estradiol in fertile cycles. Am J Obstet Gynecol 1982;143:808- 813. 
  62. Sherman, B. M. & Korenman, S. G. Hormonal characteristics of the human menstrual cycle throughout reproductive life. Journal of Clinical Investigation 1975;55:699-706. 
  63. Richelson, L.S., Wahner,H.W., Melton, L.J, Riggs,B.L. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. New England Journal of Medicine 331:1273-75.
  64. Wactawski-Wende J, Grossi SG, Trevisan M, et al. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol 1996;67(10 Suppl):1076-84. 
  65. Kribbs PJ, Chestnut CH 3rd, Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in an osteoporotic population. J Prosthet Dent 1989;62:703-7. 
  66. Trott JR. A histological investigation into keratinisation found in human gingiva. Br Dent J 1957;103:421-427.
  67.  Streckfus CF, Baur U, Brown LJ, Bacal C, Metter J, Nick T. Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 1998;44:32-39. 
  68. Friedlander AH. The physiology, medical management and oral implications of menopause. J Am Dent Assoc 2002;133:73-81. 
  69. Kenemans P, Van Unnik GA, Mijatovic V, van der Mooren MJ. Perspectives in hormone replacement therapy. Maturitas 2001;38Suppl:S41- 48.
  70. Grodstein F, Coldditz GA, Stampfer MJ. Post-menopausal hormone use and tooth loss: a prospective study. J Am Dent Assoc 1996;127:370- 377. 
  71. Norderd OM, Grossi SG, Machtei EE. Periodontal status of women taking postmenopausal oestrogen supplementation. J Periodontol 1993; 64: 957-62.
  72. Krall EA, Dawson- Hughes B, Hannan Mt, Kiel DP. Postmenopausal estrogen replacement and tooth retention. Compend Contin Educ Dent Suppl 1998;22:S17-22. 
  73. Rubin, J. S., Bottaro, D. P., Chedid, M., Miki, T., Ron, D., Cheon, G., Taylor, W. G., Fortney, E., Sakata, H., Finch, P. W. & LaRochelle, W. J. Keratinocyte growth factor. Cell Biology International 1995; 19: 399–411.
HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.